Status:
COMPLETED
Framingham: Inflammation, Genes & Cardiovascular Disease
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Atherosclerosis
Cardiovascular Diseases
Eligibility:
All Genders
Brief Summary
To investigate the contribution of genetic and environmental factors to vascular inflammation, and to define the extent to which inflammatory phenotypes and genotypes predict subclinical and clinical ...
Detailed Description
BACKGROUND: Recent experimental and clinical studies support the concept that vascular inflammation is central to the development of atherosclerosis, and that systemic inflammatory markers predict a ...
Eligibility Criteria
Inclusion
- Offspring \& Generation 3
Exclusion
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
7374 Patients enrolled
Trial Details
Trial ID
NCT00083863
Start Date
June 1 2004
End Date
May 1 2009
Last Update
August 12 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.